Lurbinectedin is a medication used in the treatment of certain types of cancer. It is marketed under the brand name Zepzelca [1]. According to the Mayo Clinic, some of the common side effects of Lurbinectedin include fatigue, nausea, vomiting, decreased appetite, constipation, and diarrhea. Patients may also experience hair loss, changes in taste, and muscle pain [2].

In addition to these common side effects, Lurbinectedin may also cause more serious adverse reactions. The medication can cause a decrease in the number of white blood cells, which can increase the risk of infection. Patients may also experience anemia, which can cause fatigue, shortness of breath, and dizziness. Lurbinectedin may also cause liver damage, which can lead to symptoms such as yellowing of the skin and eyes, dark urine, and abdominal pain [2].

Patients who experience any of these more serious side effects should contact their healthcare provider immediately. It is important to note that not all patients will experience these side effects, and some may experience side effects not listed here. Patients should talk to their healthcare provider about the risks and benefits of Lurbinectedin and any potential side effects before starting treatment [3].

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/LURBINECTEDIN
[2] https://www.mayoclinic.org/drugs-supplements/lurbinectedin-intravenous-route/side-effects/drg-20490804?p=1
[3] https://www.zepzelca.com/zepzelca-side-effects/